Summary.-Intracellular fluorescence polarization (IFP) values of normal human lymphocytes and leukaemic cells from newly diagnosed patients were determined from fluorescence polarization using fluorescein diacetate (FDA). Thirty healthy donors and 40 patients with various types of leukaemia (20 myelogenous and 20 lymphocytic) were included in the present studies. The result was that myeloid cells had about twice the polarization value of lymphocytic cells. The use of FDA for the determination of IFP appears to be useful for differential diagnosis, at least between acute myelogenous and lymphocytic leukaemias. These 2 types of leukaemia also showed a pronounced difference in fluorescence intensity when treated with FDA, perhaps owing to a difference in uptake velocity. The previously described membrane microviscosity using 1,6-diphenyl-1,3,5-hexatriene (DPH), however, did not show such a difference between these 2 leukaemias.
Summary.-Intracellular fluorescence polarization (IFP) values of normal human lymphocytes and leukaemic cells from newly diagnosed patients were determined from fluorescence polarization using fluorescein diacetate (FDA) . Thirty healthy donors and 40 patients with various types of leukaemia (20 myelogenous and 20 lymphocytic) were included in the present studies. The result was that myeloid cells had about twice the polarization value of lymphocytic cells. The use of FDA for the determination of IFP appears to be useful for differential diagnosis, at least between acute myelogenous and lymphocytic leukaemias. These 2 types of leukaemia also showed a pronounced difference in fluorescence intensity when treated with FDA, perhaps owing to a difference in uptake velocity. The previously described membrane microviscosity using 1,6-diphenyl-1,3,5-hexatriene (DPH), however, did not show such a difference between these 2 leukaemias.
The fluorescein-binding protein(s) was also investigated in order to clarify its effect on IFP, but there seemed little evidence for the existence of any such dyebinding protein(s). The advantages of the present method, using FDA, reside in its simplicity, rapidity and considerable sensitivity, requiring a small sample of blood usually <5 ml.
A PRECISE DIAGNOSIS and classification of leukaemia play a critical role in the choice of treatment regimes. A prompt differential diagnosis of acute myelogenous leukaemia (AML) and acute lymphoblastic leukaemia (ALL), and that of myeloblastic and lymphoblastic crises of chronic myelogenous leukaemia (CML) are particularly important, since their responses to drugs and prognoses are greatly different (Clarkson et al., 1975; Body & Rodriguez, 1978; Rosenthal et al., 1.977; Forman et al., 1977) . Morphological differentiation alone is insufficient for exact classification (Bennet et al., 1976) , because leukaemic cells are frequently so bizarre or atypical in appearance that morphological categorization is not always objective or precise. Alternatively, various biochemical and immunological techniques have been established and utilized for cell classification (Greaves & Janossy, 1978) . More recently, flow cytometry was introduced for this purpose (Andreeff et al., 1980) . So far, however, any such single method alone is inadequate for a definite classification or evaluation of prognosis, and the combined use of a number of tests is essential in some difficult cases. Thus, simpler and more reliable methods will be useful for such purposes.
Fluorescence-polarization techniques have been used to determine membrane microviscosity (Shinitzky & Inbar, 1976) or structuredness of cytoplasmic matrix (SCM, or cytoplasmic fluidity) of living cells (Cercek & Cercek, 1977) . For the determination of membrane microvis-cosity, fluorescent lipophilic probe, 1,6-diphenyl-1 ,3,5-hexatriene (DPH), has been used (Shinitzky & Inbar, 1976) though DPH is also known to bind to internal membranes and lipid droplets in the cell (Collard & DeWildt, 1978) . For the cytoplasmic probe a fluorogenic reagent, fluorescein diacetate (FDA), nonfluorescent by itself, is used (Rotman & Papermaster, 1966) . FDA is unique in that it is taken up only by viable cells, and is subsequently hydrolysed by intracellular esterases to yield fluorescent fluorescein as described by Rotman and Papermaster (1966) and the degree of fluorescence polarization (P) of fluorescein can be readily determined (e.g. Cercek & Cercek, 1977) .
In this study we measured P values of various types of purified leukaemic cells from freshly diagnosed leukaemic patients, using DPH and FDA. Furthermore, the fluorescence intensity due to uptake of FDA was also determined simultaneously. The present data appear to be useful for a differential diagnosis of lymphocytic and myelogenous leukaemia, with simple instrumentation, by virtue of their markedly different intracellular fluorescence polarization (IFP).
MATERIALS AND METHODS
Patients-.Blood samples were obtained from hospitalized and ambulatory patients in several local hospitals (Table J) (Henderson, 1977) (Hinuma et al., 1967) , Daudi (Klein et al., 1968) and NC-37 (C-6) (Durr et al., 1970) (Lozzio & Lozzio, 1973 Separation of mononuclear cells.-Mononuclear cells were separated from fresh heparinized peripheral blood or marrow aspirates obtained from patients and healthy donors by Ficoll-Conray density gradient centrifugation. They were washed x 3 with Eagle's minimum essential medium and resuspended with RPMI-1640 (both from Nissui Seiyaku Co. Ltd, Tokyo) supplemented with 10% foetal calf serum (Grand Island Biological Co., Grand Island, N.Y.) at a concentration of 106 cells/ml. The percentage of leukaemic cells in test samples was based on a Giemsa-stained film of each preparation.
Measurement of P values with DPH. Labelling of cells with DPH was performed according to the method described by Inbar et al. (1974) . Briefly, a solution of 2 x 10-3M DPH in tetrahydrofuran (spectrograde) was diluted 1000-fold by injection into vigorously stirred O-O1M phosphate-buffered 0-15M NaCl, pH 7 0 (PBS). The DPH dispersion was mixed 1:1 (v/v) with cell suspensions and incubated for 1 h at 25°C. The labelled cells were then washed x 3, resuspended in PBS, and immediately used for fluorescence measurement at 370C.
Measurement of intracellular fluorescence polarization (IFP) value with FDA.-The cells prepared as described above were incubated for 30 min at 37TC, washed and resuspended in PBS at a concentration of 5 x 105 cells/ml. The suspension in 2 ml was transferred into a cuvette and placed in the thermostated cuvette holder and held for more than 5 min at 300C. A stock solution of FDA was prepared as follows: FDA (20 mg) was initially dissolved in 1 ml of chloroform (spectrograde) which was then diluted with PBS (pH 6.8) under vigorous stirring to give a concentration of 25 ,uM, and stored frozen until use. A 50,1I aliquot of FDA stock solution was added to a cuvette, followed by thorough mixing (by inverting the cuvette several times covered with a piece of parafilm). The cuvette was immediately placed in a thermostated spectropolarimeter at 30TC, and measurement was started. P values and fluorescence intensity were obtained automatically in print-outs. Detailed assessment of these assay conditions will be published elsewhere.
Instruments.-Polarization spectrofluorometry was performed with a JIMCO polarization spectrofluorometer Model MAC-2 Type HR-1 (Japan Immunoresearch Co., Ltd, Takasaki, Japan). This instrument was equipped with some novel features, such as a rotating analyser polarizer which permits use of only a single photomultiplier, and use of a high-performance 3-cavity filter, as described by Maeda (1979) . For the measurement of P values of the fluorescein probe, an excitation filter for 490 nm and an emission filter with band path maximum at 520 nm were used. For DPH an excitation filter for 365 nm was used. All these filters were obtained from Ditric Optics Inc., Hudson, Mass., U.S.A. For the emission of DPH, a cut-off filter (an aqueous solution of IM NaNO2 in a 10mm cuvette which cuts the wavelength below 390 nm (Shinitzky & Inbar, 1974) ) was used.
A refrigerated water circulator Model RTE-8 (Neslab Inst. Inc., Portsmoutb, N.H., U.S.A.) was used to keep the operating temperature constant within + 0.05°C.
The results were expressed as P, which is standardized to a mean of real P at 10, 15 and 20 min after FDA addition. Fluorescence tn icroscopy.-An established cell line (K/TB) and some leukaemic cells wvere used to confirm the intracellular location of the fluorochrome. The cells wNere washed twice ith PBS and resuspended in PBS before use. A small drop of cell suspension as placed on a glass slide, followed bay subsequent addition of 5 ,ul of FDA stock solution, and fluorescence microscopy was then performed at room temperature.
RESULTS
Fluorescence intensity nteasurenent and microscopy in leukaemic cells Immediately after the addition of FDA to the cell suspensions, fluorescence was apparent in the cytoplasm (including microgranules and cytosoi) as well as in the nucleus, but to a lesser extent in the cytoplasmic membrane, under fluorescence microscopy ( Fig. 1) . The fluorescence intensity became detectable by the instrument after 5-10 min, and continued to increase for 20-30 min (Fig. 2) and the cells remained fluorescent for more than 30 min.
Uptake velocity of FDA, which was calculated from the increased fluorescence intensity of free fluorescein in a given time, was generally higher in myeloid than in lymphoid leukaemic cells, though there was some variation within each group (Fig. 2 and 3) .
The release of fluorescein from cells after 30 min was undetectable (< 0 pmol/ml) under our conditions, from the measured fluorescence intensity of the supernatant of the cell suspension after centrifugation (1200 rev/min for 10 min).
Intracellularfluorescence polarization values of leukaemic cells
The results showed a marked difference between lymphocytic and myelogenous leukaemias in P (Table I 0 007 (n = 3), 0-278 + 0-029 (n = 4), respectively, with small deviations. Cells from CML, including acute crisis and a rare case of chronic neutrophilic leukaeinia, had a P of 0-261 + 0 016 (n = 4), identical to that of AML. On the contrary, P for leukaemic cells of ALL (P = 0 125 + 0.045, n = I0) were significantly lower than those of myelogenous leukaemia (P < 0-001) or mononuclear cells from normal donors (P=0-187+0X017, n=30) (0X001<P< 0-01). Other types of lymphocytic leukaemic cells, CLL (T, B and Null-cell types), Waldenstrom's macroglobulinaemia, and non-Hodgkin's malignant lymphomas, had comparable P to ALL (0.172 +0007; n=3, 04121, n=l and 0-168+ 0-040, n=3 respectively), although one case of adult T-cell leukaemia had rather a high value (P = 0 205) (Fig. 4) . over normal lymphocytes (P =0*251 + 0 001, n= 17). Myelogenous leukaemic cells had a P of 0-236+0-019 (n=13) comparable to that of lymphocytic leukaemic cells. However, some of these leukaemic cells, e.g. CML (P = 0.252 + 0-020, n = 4), had P values close to those of normal lymphocytes. There seems to be no significant difference in the membrane fluidity or DPH-bound lipid components among different classes of lymphocytic and myelogenous leukaemia, as measured by DPH. there are any correlations between these 1975; Ellis et al., 1978) . Among them, the groups and clinical and laboratory findings, terminal deoxynucleotidyl transferase response to treatment and prognosis assay has proved to be invaluable in  Gordon et al., 1978; Janossy et al., 1980) . A definite diagnosis into these 2 broad categories is important for urgent treatment or further classification. In spite of its high reliability, however, it is not always practical due to highly elaborate procedures. Alternatively, several laboratories have reported successful production of heterologous antisera (Greaves & Janossy, 1978) . But absorption of nonspecific reactants in such sera is essential, to make such antisera specific for neoplastic cells, though it is a formidable task. Present methods of measuring IFP with FDA seem to be useful, at least for the differentiation of myelogenous and lymphoblastic leukaemias, AML having apparently about 5000 higher P value than ALL. Two groups showed little overlapping in P (Table I , Fig. 2A, Fig. 4) . Furthermore, our results indicate the interesting fact that the IFPs of various types of chronic acute leukaemias corresponding to either myelogenous or lymphocytic lineages (Fig.  4A-C) . Therefore it is tempting to speculate that the observed difference in IFP reflects the intrinsic biological properties of the respective cells, which are determined at an early stage of haematological differentiation and are retained during the course of differentiation. Cercek & Cercek (1977) have reported that P values of lymphocytes from leukaemic patients were reduced in CML, CMML (chronic myelomonocytic leukaemia), AML and CLL. It is not clear, however, what percentage of leukaemic or primitive cells was used. Since the purpose of their work was to investigate the response of lymphocytes, but not of leukaemic cells, to PHA or so-called cancer basic protein, the P value could represent primarily that of normal lymphocytes of the patients. In our assay, peripheral mononuclear cells, primarily consisting of leukaemic cells, were used (Table I) . Thus, P value in this report represents that of leukaemic cells. A few cases (Nos. 1*, 5, 20, 23*) with mostly normal mononuclear cells, showed results concordant with Cercek & Cercek (1977) , including exceptionally low P in AML. It is anticipated, on the basis of the above result, that the cells to be subjected to the present analysis should contain at least 5000 leukaemic cells in the population for a reliable assay.
IFP measured with FDA represents the rotational Brownian motion of fluorescein molecules in cells, thus it may indicate the intracellular fluidity. However, this value is possibly influenced by interaction of fluorescein and intracellular binding protein (Epstein et al., 1977; Udkoff & Norman, 1979) , local pH, altered fluorescence decay time, hydrophobicity and, most likely, fluidity of the microenvironment where the probe (fluorescein) exists. We investigated the possible presence of fluorescein-binding protein, particularly in myelogenous leukaemic cells, which showed higher P than lymphoblastoid cells. However, experiments with the 2 cell types exhibited similar results and little evidence of binding proteins (not shown) as revealed by a Sephadex dye-binding experiment (Hummel & Dreyer, 1962; Maeda et al., 1969) and by fluorescence polarization, which measured fluorescein-protein interaction (Brodrick et al., 1980) . Secondly we examined the intracellular pH, a factor known to influence the P value of fluorescein, of representative leukaemic cells as well as of 4 different cell lines, based on spectroscopy (Thomas et al., 1979) . There was only a slight difference in the intracellular pH (6.0-6.7), which would do very little to change P (data not shown, < 5%). Therefore the difference of P values between the cell types appears most likely to result from the difference in the intrinsic intracellular fluidity of each cell lineage. In addition to P value, myeloid leukaemic cells showed more rapid uptake of FDA than lymphoid cells (Table I, Fig.  2B, Fig. 3A, B) . This uptake velocity represents the rate of penetration of FDA into the cytosol, as well as the rate of enzymatic hydrolysis of FDA into fluorescein (esterase activity). However, it is not clear whether FDA transport or esterase activity is more responsible for this fact. Since myeloid cells are generally larger than lymphoid leukaemic cells, the higher uptake velocity of the former is a logical consequence. None the less, this difference of FDA uptake could be used as another parameter for the differentiation between these 2 leukaemias. As the P value is independent of concentration of fluorochrome (as shown in Perrin's equation; see footnote*), the difference in the fluorescence intensity is not the cause of the difference in P. Since the fluorescence yielding P is observed primarily in the cytosol and nucleus (Fig. 1) but not on the membrane, the measured P can be regarded as that of cytosol (including microsomes) and nucleus as well.
P probed by DPH has been measured to discriminate between normal and malignant lymphocytes. Inbar, Shinitzky and co-workers have reported a marked increase in the fluidity of plasma-membrane lipid of malignant lymphoid cells over normal lymphocytes (Inbar et al., 1974; Shinitzky & Inbar, 1974; Petitou et al., 1978) . This difference in apparent microviscosity is ascribed mainly to a lowered cholesterol/phospholipid ratio in the leukaemic cells (Shinitzky & Inbar, 1974; Petitou et al., 1978) . In addition, the ratio of saturated to unsaturated fatty acid is also known to involve the membrane viscosity (Yamane & Tomioka, 1979) . Blecher & Bisby (1977) extended this method to various types of human leukaemia. The data obtained in the present study are in accordance with those of Inbar and Blecher (Table II) . Furthermore, similar results were found with AML cells in the present investigation. Contrary to the fluorescence polarization method using FDA, however, the use of DPH yielded no significant differences among types of cell. This indicates that the membrane fluidity or DPH-binding lipid components in cells, but not the intracellular fluidity, differs very little among the different cell types.
The advantage of the present method is simplicity, rapidity (about 2 h in total) and considerable sensitivity, requiring usually < 5 ml of peripheral blood. This method appears to be invaluable to the upgrading of the above-mentioned differential diagnosis of leukaemias, when used in combination with recently developed methods with membrane and enzyme markers. P.=a constant (maximal value of P in a rigid medium). R = gas constant (8-314 x 107 ergs/degree centigrade/mol).
T =absolute temperature (K). 7 =viscosity (poise).
=interval betwe3n excitation and emission of fluoroclirom-(a characteristic of tlih) molecular species) (seconds). V =molecular volume of the fluorescent rotational unit (cm3).
The above equation indicates that P is independent of the concentrationi of the fluorophore. T will depend upon changes in electronic state of the fluorochrome (pH) or the dielectric constant of the solution (hydroplhobicity of environment).
